|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0008838,
umls-concept:C0010583,
umls-concept:C0029246,
umls-concept:C0035168,
umls-concept:C0085752,
umls-concept:C0087111,
umls-concept:C0205179,
umls-concept:C0205195,
umls-concept:C0238122,
umls-concept:C0239307,
umls-concept:C0282460,
umls-concept:C1257890,
umls-concept:C1516985,
umls-concept:C2603343
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2001-8-14
|
|
pubmed:abstractText |
To investigate the clinical activity and toxicity of a combination chemotherapy consisting of cyclophosphamide (C), adriamycin (A) and cisplatin (P) for patients with primary adenocarcinoma of the Fallopian tube having FIGO stage III-IV disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0392-2936
|
|
pubmed:author |
pubmed-author:Bokkel-HuininkW TWT,
pubmed-author:BolinJJ,
pubmed-author:CurranDD,
pubmed-author:ForsBB,
pubmed-author:GoupilAA,
pubmed-author:HerbenM GMG,
pubmed-author:KerbratPP,
pubmed-author:KobierskaAA,
pubmed-author:LacaveA JAJ,
pubmed-author:MadronalCC,
pubmed-author:MangioniCC,
pubmed-author:MarthC HCH,
pubmed-author:NooijM AMA,
pubmed-author:PecorelliSS,
pubmed-author:TumoloSS,
pubmed-author:VergoteII,
pubmed-author:VermorkenJ BJB,
pubmed-author:WagenaarH CHC,
pubmed-author:WagenerD JDJ,
pubmed-author:ZanaboniFF,
pubmed-author:de OliveiraC FCF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
187-93
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11501769-Adenocarcinoma,
pubmed-meshheading:11501769-Aged,
pubmed-meshheading:11501769-Antibiotics, Antineoplastic,
pubmed-meshheading:11501769-Antineoplastic Agents, Alkylating,
pubmed-meshheading:11501769-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11501769-Cisplatin,
pubmed-meshheading:11501769-Cyclophosphamide,
pubmed-meshheading:11501769-Doxorubicin,
pubmed-meshheading:11501769-Drug Administration Schedule,
pubmed-meshheading:11501769-Europe,
pubmed-meshheading:11501769-Fallopian Tube Neoplasms,
pubmed-meshheading:11501769-Female,
pubmed-meshheading:11501769-Humans,
pubmed-meshheading:11501769-Middle Aged,
pubmed-meshheading:11501769-Neoplasm Staging,
pubmed-meshheading:11501769-Survival Analysis,
pubmed-meshheading:11501769-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer.
|
|
pubmed:affiliation |
Department of Gynecology, Leiden University Medical Center, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
